Source: Annual Congress 2002 - Acute exacerbations of COPD: aetiology and therapy
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Zervos, S. Jenkins, R. Nusrat (Royal Oak, Bridgewater, United States Of America). Telithromycin is effective in the treatment of patients with acute exacerbations of chronic bronchitis and risk factors for morbidity. Eur Respir J 2002; 20: Suppl. 38, 3378

Member's Comments

No comment yet.

Related content which might interest you: Incidence and risk factors of acute exacerbations of COPD in Italy Source: Eur Respir J 2001; 18: Suppl. 33, 152s Year: 2001 Risk factors for hospitalization of an acute exacerbation of COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 177s Year: 2006 Long-term benefits of antibiotic treatment in reducing recurrence rates and resource utilization in acute exacerbations of chronic bronchitis (AECB) Source: Annual Congress 2003 - Outcome of acute exacerbations in COPD Year: 2003 Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis Source: Eur Respir J 2001; 17: 928-933 Year: 2001 Efficacy of levofloxacin (LVF) in the treatment of acute exacerbations of chronic bronchitis (AECB) in patients with risk factors Source: Annual Congress 2003 - Acute exacerbations of asthma and COPD Year: 2003 Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 An observational study of risk factors for hospitalization of chronic obstructive pulmonary disease exacerbation and their outcome Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD Source: Eur Respir J 2009; 33: 282-288 Year: 2009 Acute exacerbations of COPD: The influence of comorbidities and chronic medication on mortality and exacerbation rate Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Factors affecting in-hospital mortality in patients with chronic obstructive pulmonary disease exacerbation Source: Annual Congress 2013 –The latest insights in chronic care Year: 2013 Early readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is associated with high mortality Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Coexisting cardiovascular diseases increase the risk of exacerbations in patients with COPD Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Prevalence and risk factors for Aspergillus spp. colonization in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD): The multi-center FUNGI-COPD study Source: Annual Congress 2010 - Various aspects of respiratory epidemiology Year: 2010 Predictive factors of 90-days post-discharge COPD acute exacerbation’s recurrence Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations Source: Eur Respir J, 53 (4) 1900147; 10.1183/13993003.00147-2019 Year: 2019 Predictors of mortality in COPD during acute exacerbation Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Risk factors for early readmission after acute exacerbation of chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Risk factors for severe exacerbations in a real-life population of adults with severe refractory asthma Source: International Congress 2017 – Many faces of asthma and allergies Year: 2017